Literature DB >> 34213090

More than just acral melanoma: the controversies of defining the disease.

Sara S Bernardes1,2, Ingrid Ferreira3,4, David E Elder5, Aretha B Nobre6,7, Héctor Martínez-Said8, David J Adams3, Carla Daniela Robles-Espinoza3,9, Patricia A Possik1.   

Abstract

Acral melanoma (AM) is a malignant cutaneous melanocytic tumour specifically located on the palms, soles, and nail apparatus, which are areas of glabrous (hairless) skin. Acral lentiginous melanoma, a subtype of AM, represents a histopathological subtype diagnosis of cutaneous melanoma with unique morphological and structural features. Despite clear definitions, the misuse of these terms and the inconsistency in reporting the histopathological features of AM cases have become a major obstacle to the study of the disease. In this review, we discuss the epidemiology, histopathological features, prognosis, and genetic profile of AM, highlighting the differences observed when histopathological subtypes are considered. The increasing global effort to characterise AM cases from ethnically diverse populations would benefit greatly from a more consistent classification of the disease.
© 2021 The Authors. The Journal of Pathology: Clinical Research published by The Pathological Society of Great Britain and Ireland & John Wiley & Sons, Ltd.

Entities:  

Keywords:  acral melanoma; epidemiology; genetics; histopathology; prognosis

Mesh:

Substances:

Year:  2021        PMID: 34213090      PMCID: PMC8503895          DOI: 10.1002/cjp2.233

Source DB:  PubMed          Journal:  J Pathol Clin Res        ISSN: 2056-4538


  110 in total

Review 1.  Controversies in acral lentiginous melanoma.

Authors:  Jennifer R Stalkup; Ida F Orengo; Rajani Katta
Journal:  Dermatol Surg       Date:  2002-11       Impact factor: 3.398

2.  KIT, NRAS, BRAF and PTEN mutations in a sample of Swedish patients with acral lentiginous melanoma.

Authors:  Abdlsattar Zebary; Katarina Omholt; Ismini Vassilaki; Veronica Höiom; Diana Lindén; Lisa Viberg; Lena Kanter-Lewensohn; Carolina Hertzman Johansson; Johan Hansson
Journal:  J Dermatol Sci       Date:  2013-08-08       Impact factor: 4.563

3.  Detecting copy number alterations of oncogenes in cell-free DNA to monitor treatment response in acral and mucosal melanoma.

Authors:  Asuka Mikoshiba; Atsuko Ashida; Kaori Sakaizawa; Yukiko Kiniwa; Ryuhei Okuyama
Journal:  J Dermatol Sci       Date:  2020-01-15       Impact factor: 4.563

4.  Acral lentiginous melanoma: clinicopathological characteristics and survival outcomes in the US National Cancer Database 2004-2016.

Authors:  S Behbahani; S Malerba; F H Samie
Journal:  Br J Dermatol       Date:  2020-06-28       Impact factor: 9.302

5.  The 2018 World Health Organization Classification of Cutaneous, Mucosal, and Uveal Melanoma: Detailed Analysis of 9 Distinct Subtypes Defined by Their Evolutionary Pathway.

Authors:  David E Elder; Boris C Bastian; Ian A Cree; Daniela Massi; Richard A Scolyer
Journal:  Arch Pathol Lab Med       Date:  2020-02-14       Impact factor: 5.534

6.  Clinical and genetic analysis of melanomas arising in acral sites.

Authors:  Anne Zaremba; Rajmohan Murali; Philipp Jansen; Inga Möller; Antje Sucker; Annette Paschen; Lisa Zimmer; Elisabeth Livingstone; Titus J Brinker; Eva Hadaschik; Cindy Franklin; Alexander Roesch; Selma Ugurel; Dirk Schadendorf; Klaus G Griewank; Ioana Cosgarea
Journal:  Eur J Cancer       Date:  2019-08-14       Impact factor: 9.162

7.  Significance of dermoscopic patterns in detecting malignant melanoma on acral volar skin: results of a multicenter study in Japan.

Authors:  Toshiaki Saida; Atsushi Miyazaki; Shinji Oguchi; Yasushi Ishihara; Yoriko Yamazaki; Sumio Murase; Shusuke Yoshikawa; Tetsuya Tsuchida; Yasuhiro Kawabata; Kunihiko Tamaki
Journal:  Arch Dermatol       Date:  2004-10

8.  Acral melanoma. A clinicopathologic study of 28 patients.

Authors:  C S Lin; W J Wang; C K Wong
Journal:  Int J Dermatol       Date:  1990-03       Impact factor: 2.736

9.  Distinct genomic traits of acral and mucosal melanomas revealed by targeted mutational profiling.

Authors:  Zhengyun Zou; Qiuxiang Ou; Yu Ren; Qing Lv; Lanqun Qin; Lianjun Zhao; Shu Su; Xue Wu; Hua Bao; Ao Wang; Dongqin Zhu; Xiaonan Wang; Yang W Shao; Baorui Liu
Journal:  Pigment Cell Melanoma Res       Date:  2020-01-27       Impact factor: 4.693

10.  Aberrant hTERT promoter methylation predicts prognosis in Chinese patients with acral and mucosal melanoma: A CONSORT-compliant article.

Authors:  Haixia Xu; Weijia Wang; Juan Zhao; Tingting Li; Xiaojing Kang
Journal:  Medicine (Baltimore)       Date:  2019-10       Impact factor: 1.817

View more
  2 in total

1.  Cell position matters in tumour development.

Authors:  Jean-Christophe Marine; María S Soengas
Journal:  Nature       Date:  2022-04       Impact factor: 49.962

2.  Cutaneous and acral melanoma cross-OMICs reveals prognostic cancer drivers associated with pathobiology and ultraviolet exposure.

Authors:  Zdenko Herceg; Vinicius de Lima Vazquez; Akram Ghantous; Anna Luiza Silva Almeida Vicente; Alexei Novoloaca; Vincent Cahais; Zainab Awada; Cyrille Cuenin; Natália Spitz; André Lopes Carvalho; Adriane Feijó Evangelista; Camila Souza Crovador; Rui Manuel Reis
Journal:  Nat Commun       Date:  2022-07-15       Impact factor: 17.694

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.